Solli O - Search Results

1

Health-related quality of life in diabetes: The associations of complications with EQ-5D scores.

Solli O, Stavem K, Kristiansen IS. Solli O, et al. Health Qual Life Outcomes. 2010 Feb 4;8:18. doi: 10.1186/1477-7525-8-18. Health Qual Life Outcomes. 2010. PMID: 20132542 Free PMC article.

2

Diabetes: cost of illness in Norway.

Solli O, Jenssen T, Kristiansen IS. Solli O, et al. BMC Endocr Disord. 2010 Sep 20;10:15. doi: 10.1186/1472-6823-10-15. BMC Endocr Disord. 2010. PMID: 20854689 Free PMC article.

3

A cost-utility analysis of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction.

Hansen SA, Aas E, Solli O. Hansen SA, et al. Among authors: solli o. Eur J Health Econ. 2020 Feb;21(1):73-84. doi: 10.1007/s10198-019-01112-8. Epub 2019 Sep 11. Eur J Health Econ. 2020. PMID: 31512069

4

Changes in primary care management of atrial fibrillation patients following the shift from warfarin to non-vitamin K antagonist oral anticoagulants: a Norwegian population based study.

Halvorsen S, Smith JA, Söderdahl F, Thuresson M, Solli O, Ulvestad M, Jonasson C. Halvorsen S, et al. Among authors: solli o. BMC Prim Care. 2022 Aug 25;23(1):214. doi: 10.1186/s12875-022-01824-6. BMC Prim Care. 2022. PMID: 36008778 Free PMC article.

5

A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants.

Halvorsen S, Ghanima W, Fride Tvete I, Hoxmark C, Falck P, Solli O, Jonasson C. Halvorsen S, et al. Among authors: solli o. Eur Heart J Cardiovasc Pharmacother. 2017 Jan;3(1):28-36. doi: 10.1093/ehjcvp/pvw031. Epub 2016 Sep 27. Eur Heart J Cardiovasc Pharmacother. 2017. PMID: 27680880 Free PMC article.

6

Overall survival in renal cell carcinoma after introduction of targeted therapies: a Norwegian population-based study.

Beisland C, Johannesen TB, Klepp O, Axcrona U, Torgersen KM, Kowalski J, Solli O, Sandin R, Oldenburg J. Beisland C, et al. Among authors: solli o. Onco Targets Ther. 2017 Jan 16;10:371-385. doi: 10.2147/OTT.S123061. eCollection 2017. Onco Targets Ther. 2017. PMID: 28144152 Free PMC article.

7

Introduction of new health technologies - is the patient being heard?

Mwaura D, Solli O, Hjelvin E. Mwaura D, et al. Among authors: solli o. Tidsskr Nor Laegeforen. 2022 Apr 4;142(6). doi: 10.4045/tidsskr.22.0068. Print 2022 Apr 5. Tidsskr Nor Laegeforen. 2022. PMID: 35383438 Free article. English, Norwegian. No abstract available.

8

[Health data – a simple method for a better insight].

Solli O, Halkinrud M. Solli O, et al. Tidsskr Nor Laegeforen. 2021 Oct 11;141(2021-14). doi: 10.4045/tidsskr.21.0633. Print 2021 Oct 12. Tidsskr Nor Laegeforen. 2021. PMID: 34641649 Free article. Norwegian. No abstract available.

9

Good reasons for confidential drug prices.

Østby JT, Solli O. Østby JT, et al. Among authors: solli o. Tidsskr Nor Laegeforen. 2019 Mar 11;139(5). doi: 10.4045/tidsskr.19.0106. Print 2019 Mar 12. Tidsskr Nor Laegeforen. 2019. PMID: 30872829 Free article. English, Norwegian. No abstract available.

10

[Local anesthetics derived from p-cymene and mesitylene].

Samdahl B, Solli O, Staalesen Y. Samdahl B, et al. Among authors: solli o. Ann Pharm Fr. 1965 May;23(5):355-62. Ann Pharm Fr. 1965. PMID: 5840951 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page